151001153931 1 900x600
Alzprotect 20logo

Alzprotect

Alzprotect is a biotechnology company developing innovative therapeutic solutions for neurodegenerative diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Loos, France
  • Currency EUR
  • Founded November 2007
  • Employees 10
  • Incorporation Type Not Incorporated
  • Website alzprotect.com

Company Summary

Alzprotect's mission is to develop medicines for the treatment of neurodegenerative diseases from research excellence proof of concept in patients and to sell the license to a pharmaceutical partner or sell the company.
AZP2006 differs from competing molecules by addressing all the causes of the disease, including Ab toxicity, Tau phosphorylation, oxidative stress and neuroinflammation through Its innovative mechanism of action.

Team

  • Default avatar
    Stéphane Burlet
    Preclinical manager

    18 years experience , Trophos

  • Default avatar
    Cécilia Estrella
    Pharmacology manager

    Neuropharmacologist 20 years experience in R&D

  • Ac704650 d543 4d67 a48f 9cba9bfaa8c9
    President and CSO

    Philippe Verwaerde is President and CEO of Alzprotect, young innovative company in the field of neurodegenerative diseases. He has previously worked in the field of pharmacology within pharmaceutical and biotech companies. His international career took him from France to the United States, Italy, Belgium, and Sweden leading research teams as laboratory manager and department director before becoming an entrepreneur.

  • Default avatar
    Laurent Dupire, PhD
    CEO

    Well-established national network
    Co-founder of a biotechnology company
    Coached the launch of several activities in different sectors: biotechnology, computer science, software

Advisors

Previous Investors